96-24213. Notice Pursuant to the National Cooperative Research and Production Act of 1993the Ohio Aerospace Institute Computer Assisted Minimally Invasive Surgery Project  

  • [Federal Register Volume 61, Number 184 (Friday, September 20, 1996)]
    [Notices]
    [Page 49484]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 96-24213]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF JUSTICE
    Antitrust Division
    
    
    Notice Pursuant to the National Cooperative Research and 
    Production Act of 1993--the Ohio Aerospace Institute Computer Assisted 
    Minimally Invasive Surgery Project
    
        Notice is hereby given that, on September 4, 1996, pursuant to 
    Section 6(a) of the National Cooperative Research and Production Act of 
    1993, 15 U.S.C. 4301 et seq. (``the Act''), the Ohio Aerospace 
    Institute Computer Assisted Minimally Invasive Surgery Project 
    (``CAMIS'') has filed written notification simultaneously with the 
    Attorney General and the Federal Trade Commission disclosing (1) the 
    identities of the parties and (2) the nature and objectives of the 
    venture. The notifications were filed for the purpose of invoking the 
    Act's provisions limiting the recovery of plaintiffs to actual damages 
    under specified circumstances. Pursuant to Section 6(b) of the Act, the 
    identities of the parties are Ohio Aerospace Institute, Brook Park, OH; 
    Cleveland Clinic Foundation, Cleveland, OH; Picker International, 
    Highland Heights, OH; Wright State University, Dayton, OH; and 
    Washington University, St. Louis, MO. The project's general area of 
    planned activity is a non-profit joint venture dedicated to research 
    and developing ``vision technologies'' that can aid doctors in various 
    surgical procedures. CAMIS will provide for the enhancement of existing 
    CAMIS prototype systems with aerospace avionics technologies, and its 
    clinical trials will concentrate on the early treatment of several 
    forms of cancer (brain tumors, prostate and breast) to demonstrate the 
    significant improvements to patient care and cost that this technology 
    provides.
        Membership in this project remains open, and CAMIS intends to file 
    additional written notification disclosing all changes in membership. 
    Information regarding participation in CAMIS may be obtained from 
    Eileen Pickett, Ohio Aerospace Institute, Cleveland, OH.
    Constance K. Robinson,
    Director of Operations, Antitrust Division.
    [FR Doc. 96-24213 Filed 9-19-96; 8:45 am]
    BILLING CODE 4410-01-M
    
    
    

Document Information

Published:
09/20/1996
Department:
Antitrust Division
Entry Type:
Notice
Document Number:
96-24213
Pages:
49484-49484 (1 pages)
PDF File:
96-24213.pdf